Physician

Hematology

Steven A. Armentrout, MD works in the field of Hematology. He studied medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. Steven Armentrout is a published physician as well. He has 46 publications published. The latest was: Chemotherapy in carcinoma of the lung.

Publications

---

• Response of a hepatocellular carcinoma to the cisplatin-vinblastine-bleomycin drug regimen.
• Partial purification and characterization of a lymphotoxic factor from multiple sclerosis serum.
• Phase I-II trial of mitoxantrone in acute leukemia.
• INHIBITION OF PROTEIN SYNTHESIS IN MAMMALIAN CELL-FREE SYSTEMS BY CHLORAMPHENICOL.
• Protein synthesis by reticulocyte ribosomes. I. Inhibition of polyuridylic acid-induced ribosomal protein synthesis by chloramphenical.
• Combination drug therapy in metastatic carcinoma of the breast.
• Myocarditis associated with rabies. Report of a case.
• THE EFFECT OF RADIATION ON ARTIFICIAL NUCLEOPROTEINS. 1. RADIOSENSITIVITY OF POLYADENYLIC ACID-POLYURIDYLIC ACID: BOVINE GAMMA-GLOBULIN COMPLEX.
• Multiple myeloma complicated by myelomatous obstructive uropathy.
• A naturally occurring complement dependent human IgM macroglobulin inhibitory to Ehrlich ascites tumor cells.
• Activated partial thromboplastin time after heparin removal (aPTT/HR) in a new scheme of anticoagulant monitoring.
• The effect of a factor from multiple sclerosis serum on isolated T and B lymphocytes.
• Successful pregnancy during chemotherapy for acute leukemia.
• Hepatic artery-biliary fistula. An unusual complication of infusion therapy.
• Hematologic complications of the elderly.
• Doxorubicin-hexamethylmelamine therapy of small cell carcinoma of the lung.
• Long-term survivors of high-grade malignant astrocytomas.
• Third trimester chemotherapy and neonatal hematopoiesis.
• Cytotoxic chemotherapy in Kaposi's sarcoma.
• Combination chemotherapy in metastatic carcinoma of the breast. Results with a three-drug combination.
• The effect of a lymphotoxic factor from patients with multiple sclerosis on acute lymphosarcoma cell leukemia and acute lymphoblastic leukemia.
• Chemotherapy in carcinoma of the lung.
• Septicemia in acute leukemia.
• Inhibition of mitogen induced blast transformation by a multiple sclerosis serum factor.
• Remission of pure red cell aplasia associated with nonthymic malignancy.
• A humoral lymphocyte transformation inhibition factor in multiple sclerosis.
• Inhibition of directed protein synthesis by chloramphenicol: effect of magnesium concentration.
• Ribonucleoprotein interaction with mammalian monosomes.
• Protein synthesis by reticulocyte ribosomes. 3. Description of a ribonucleoprotein fraction which stimulates messenger RNA-ribosomal interaction.
• Directed protein synthesis by messenger ribonucleoprotein and ribosomes from different mammalian species.
• The effect of a lymphotoxic factor in the sera of patients with multiple sclerosis and acute leukemia on the metabolism of normal and leukemic lymphocytes.
• Peptide synthesis directed by MS2 bacteriophage RNA in a mammalian cell-free system.
• Inhibition of mammalian protein synthesis by antibiotics.
• Immunoassay of hemoglobin A2.
• Early hematological abnormalities associated with chloramphenicol therapy.
• Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
• Neurological manifestations of acute granulocytic leukemia.
• "Preleukemia". A myelodysplastic syndrome often terminating in acute leukemia.
• Prediction of the response of patients with acute nonlymphocytic leukemia to cytosine arabinoside (NSC-63878) therapy.
• Comparison of postoperative irradiation alone and in combination with BCNU (NSC-409962) in the management of malignant gliomas.
• Synthesis of gamma G antibody and immunoglobulin on polyribosomes in a cell-free system.
• Stimulation of polypeptide synthesis by artificial nucleoproteins.
• Polypeptide synthesis directed by lymph node ribonucleoprotein in a reticulocyte cell-free system.
• Prolymphocytic leukemia treated by leukapheresis with relief of respiratory symptoms.
• Aplastic anemia occurring as amegakaryocytic thrombocytopenia with and without an inhibitor of granulopoiesis.

Schools

---

• University Of ChicagoThe Pritzker School Of Medicine

• University Hospital Cleveland

• University Hosps Cleveland

• Case Western Reserve University

Doctors Specialties

---

• Hematology

Accepted Insurances

---

• Aetna HMO
• Basic HMO
• Choice Plus POS II
• Vitalidad Plus California Con Aetna
• Blue Card PPO
• Blue Cross Blue Shield of California PPO
• Access Plus Savenet
• Basic PPO
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Blue & Gold HMO
• Community Care Network HMO
• Covered California - Bronze PPO
• Employer Group HMO
• Health Net PPO
• Individual and Family PPO
• WholeCare Network HMO
• PacifiCare HMO

Education

---

• Case Western Reserve University - University Hospitals
• University of Chicago Pritzker School of Medicine

Hospital

---

• St. Joseph Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Jae C. Chang, MD
	Dr. Homayoon H. Sanati, MD This Doctor is OpenDoctor Recommended.
	Dr. Chaitali S. Nangia, MD This Doctor is OpenDoctor Recommended.
	Dr. Tariq Mahmood, MD This Doctor is OpenDoctor Recommended.
	Dr. Timothy E. Byun, MD This Doctor is OpenDoctor Recommended.
	Dr. Sai-Hong I. Ou, MD This Doctor is OpenDoctor Recommended.
	Dr. Gordon D. McLaren, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Brian Kim, MD
	Dr. Deepty Bhansali, MD
	Dr. Rainer Brachmann, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard V. Huynh, MD
	Dr. Edgar M. Moran, MD This Doctor is OpenDoctor Recommended.
	Tiong S. Ong, MB BCH
	Dr. Phu N. Tran, MD
	Dr. Shih-Li Lin, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog